These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7816750)

  • 21. Improved intrapulmonary delivery of site-specific PEGylated salmon calcitonin: optimization by PEG size selection.
    Youn YS; Kwon MJ; Na DH; Chae SY; Lee S; Lee KC
    J Control Release; 2008 Jan; 125(1):68-75. PubMed ID: 18023905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary absorption enhancement of salmon calcitonin.
    Mahesh Kumar T; Misra A
    J Drug Target; 2004 Apr; 12(3):135-44. PubMed ID: 15203892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts.
    Song KH; Chung SJ; Shim CK
    J Control Release; 2005 Sep; 106(3):298-308. PubMed ID: 15979756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Encapsulation into PEG-liposomes does not improve the bioavailability of pulmonary delivered salmon calcitonin.
    Swaminathan J; Gobbo OL; Tewes F; Healy AM; Ehrhardt C
    J Aerosol Med Pulm Drug Deliv; 2014 Feb; 27(1):1-11. PubMed ID: 24252061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of oral bioavailability of salmon calcitonin through chitosan-modified, dual drug-loaded nanoparticles.
    Liu L; Yang H; Lou Y; Wu JY; Miao J; Lu XY; Gao JQ
    Int J Pharm; 2019 Feb; 557():170-177. PubMed ID: 30597264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of nasal salmon calcitonin absorption by lauroylcarnitine chloride in rats.
    Kagatani S; Shinoda T; Fukui M; Ohmura T; Hasumi S; Sonobe T
    Pharm Res; 1996 May; 13(5):739-43. PubMed ID: 8860430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved intestinal delivery of salmon calcitonin by Lys18-amine specific PEGylation: stability, permeability, pharmacokinetic behavior and in vivo hypocalcemic efficacy.
    Youn YS; Jung JY; Oh SH; Yoo SD; Lee KC
    J Control Release; 2006 Sep; 114(3):334-42. PubMed ID: 16884808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polyamidoamine dendrimers can improve the pulmonary absorption of insulin and calcitonin in rats.
    Dong Z; Hamid KA; Gao Y; Lin Y; Katsumi H; Sakane T; Yamamoto A
    J Pharm Sci; 2011 May; 100(5):1866-78. PubMed ID: 21374620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coated minispheres of salmon calcitonin target rat intestinal regions to achieve systemic bioavailability: Comparison between intestinal instillation and oral gavage.
    Aguirre TAS; Aversa V; Rosa M; Guterres SS; Pohlmann AR; Coulter I; Brayden DJ
    J Control Release; 2016 Sep; 238():242-252. PubMed ID: 27480451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement of the pulmonary absorption of (Asu1,7)-eel calcitonin by various absorption enhancers and their pulmonary toxicity in rats.
    Yamamoto A; Okumura S; Fukuda Y; Fukui M; Takahashi K; Muranishi S
    J Pharm Sci; 1997 Oct; 86(10):1144-7. PubMed ID: 9344172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversible lipidization for the oral delivery of salmon calcitonin.
    Wang J; Chow D; Heiati H; Shen WC
    J Control Release; 2003 Mar; 88(3):369-80. PubMed ID: 12644363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of polyion complex micelles to enhance the oral delivery of salmon calcitonin and transport mechanism across the intestinal epithelial barrier.
    Li N; Li XR; Zhou YX; Li WJ; Zhao Y; Ma SJ; Li JW; Gao YJ; Liu Y; Wang XL; Yin DD
    Biomaterials; 2012 Dec; 33(34):8881-92. PubMed ID: 22975427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of HPβCD-PEG microparticles for salmon calcitonin administration via pulmonary delivery.
    Tewes F; Gobbo OL; Amaro MI; Tajber L; Corrigan OI; Ehrhardt C; Healy AM
    Mol Pharm; 2011 Oct; 8(5):1887-98. PubMed ID: 21882837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of PEGylated salmon calcitonin in nasal mucosa.
    Na DH; Youn YS; Park EJ; Lee JM; Cho OR; Lee KR; Lee SD; Yoo SD; DeLuca PP; Lee KC
    J Pharm Sci; 2004 Feb; 93(2):256-61. PubMed ID: 14705183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thermosensitive drug delivery system of salmon calcitonin: in vitro release, in vivo absorption, bioactivity and therapeutic efficacies.
    Tang Y; Singh J
    Pharm Res; 2010 Feb; 27(2):272-84. PubMed ID: 19998055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transdermal absorption and stability enhancement of salmon calcitonin by Tat peptide.
    Manosroi J; Lohcharoenkal W; Götz F; Werner RG; Manosroi W; Manosroi A
    Drug Dev Ind Pharm; 2013 Apr; 39(4):520-5. PubMed ID: 22564052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo evaluation of the enhancing activity of glycyrrhizin on the intestinal absorption of drugs.
    Imai T; Sakai M; Ohtake H; Azuma H; Otagiri M
    Pharm Res; 1999 Jan; 16(1):80-6. PubMed ID: 9950283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of regional intestinal pH modulation on absorption of peptide drugs: oral absorption studies of salmon calcitonin in beagle dogs.
    Lee YH; Perry BA; Labruno S; Lee HS; Stern W; Falzone LM; Sinko PJ
    Pharm Res; 1999 Aug; 16(8):1233-9. PubMed ID: 10468025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of human insulin microcrystals and their absorption enhancement by protease inhibitors in rat lungs.
    Park SH; Kwon JH; Lim SH; Park HW; Kim CW
    Int J Pharm; 2007 Jul; 339(1-2):205-12. PubMed ID: 17451895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo preclinical evaluation of a minisphere emulsion-based formulation (SmPill®) of salmon calcitonin.
    Aguirre TA; Rosa M; Coulter IS; Brayden DJ
    Eur J Pharm Sci; 2015 Nov; 79():102-11. PubMed ID: 26349051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.